Gut bacteria linked to colorectal cancer, but study quality limits interpretation
A review found recurring bacterial patterns in colorectal cancer, alongside inconsistent findings and substantial problems with how comparison groups were selected.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Some bacteria were repeatedly more abundant in people with colorectal cancer, but the evidence was too inconsistent and vulnerable to bias for clinical use. These are associations: the review does not establish that the organisms cause cancer. Findings for colorectal polyps were even less reproducible than those for cancer.
Most studies received poor quality ratings, particularly for selecting cases and controls. The abstract provides no pooled association estimate, and inconsistent definitions make the findings difficult to compare.
What appeared repeatedly
Fusobacterium nucleatum and Parvimonas micra showed recurring enrichment in colorectal cancer samples. This consistency is a research signal, but it does not establish that measuring either organism can reliably identify cancer in an individual.
Why the controls matter
Some comparison participants had normal endoscopy results, while others were described as healthy without colonoscopy. Definitions of polyp cases also differed. These inconsistencies complicate deciding whether studies are examining the same underlying comparison.
The original publication
Systematic Review: The Relationship Between the Faecal Microbiome and Colorectal Neoplasia in Shotgun Metagenomic Studies.
Manning S, Hackney E, Dunneram Y et al.
Aliment Pharmacol Ther · 2025
- PubMed ID
- 40793873
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.